Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1615 1655
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18002385 | Chlorite In the Treatment of Acute Respiratory Distress Syndrome | Final Rejection | The Regents of the University of California |
| 17490877 | COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS | Non-Final OA | Genentech, Inc. |
| 17641124 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT BY ENHANCING ANTITUMOR IMMUNITY USING TANNIC ACID-BASED NANOCAPSULES | Non-Final OA | Purdue Research Foundation |
| 17687001 | PROCESS FOR PRODUCING A LIQUID HERBICIDAL COMPOSITION | Final Rejection | UPL LTD |
| 17616499 | COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH | Final Rejection | DUKE UNIVERSITY |
| 17779963 | DRUG-LOADED IMPLANTED MEDICAL DEVICE AND PREPARATION METHOD THEREFOR | Non-Final OA | SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD. |
| 18000491 | COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION | Final Rejection | THE UNIVERSITY OF HONG KONG |
| 18883477 | DRUG AND PRODUCTION METHOD THEREFOR | Non-Final OA | OSAKA UNIVERSITY |
| 17613783 | MONOSACCHARIDE-TAGGED NANO-LIPOSOME DRUG DELIVERY SYSTEM, THE MANUFACTURE AND USE FOR DRUG TARGETING DELIVERY THEREOF | Non-Final OA | National Yang Ming Chiao Tung University |
| 17769907 | CERAMIDE RATIOS AS PREDICTIVE AND THERAPEUTIC BIOMARKERS FOR LEUKEMIAS | Non-Final OA | University of Virginia Patent Foundation |
| 17632131 | COSMETIC | Final Rejection | SHISEIDO COMPANY, LTD. |
| 17632891 | PHARMACEUTICAL COMPOSITION COMPRISING ENSIFENTRINE | Non-Final OA | VERONA PHARMA PLC |
| 17792554 | METHODS OF PREPARING LIPID NANOPARTICLES | Non-Final OA | ModernaTX, Inc. |
| 17605891 | MAGNESIUM ION-CONTAINING MATERIALS AS WHITE PIGMENTS IN ORAL CARE COMPOSITIONS | Non-Final OA | Omya International AG |
| 18412192 | AGRICULTURAL ADMIXTURES | Non-Final OA | CALIFORNIA SAFE SOIL, LLC |
| 18537353 | Synergistic Combinations for Reducing Volatility of Auxin Herbicides | Non-Final OA | Ethox Chemicals, LLC |
| 18561642 | Agricultural Chemical Formulation | Non-Final OA | Aaron Eberle |
| 18494551 | ENHANCED MUCOUS ADHESION VIA A COMPLEX OF CARBOXYMETHYL STARCH AND PULLULAN POLYMERS | Final Rejection | Professional Compounding Centers of America, Inc. |
| 17753890 | NANOFIBER- AND NANOWHISKER-BASED TRANSFECTION PLATFORMS | Non-Final OA | NANOFIBER SOLUTIONS, LLC |
| 18234230 | CARRIER FOR SUSTAINED-RELEASE OF DRUG AND USE THEREOF | Final Rejection | KUNMING QINGCHENG HEALTHCARE TECH LTD. |
| 17640918 | PANCREATIN MICROCAPSULES | Non-Final OA | AVVA PHARMACEUTICALS LTD. |
| 18246533 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | Final Rejection | BioNTech SE |
| 18063460 | STABLE COMPOSITIONS OF VARENICLINE | Final Rejection | MANKIND PHARMA LTD. |
| 18247962 | STABILIZATION OF ANTIGENS FOR LONG TERM ADMINISTRATION IN TRANSDERMAL MICRONEEDLE PATCHES | Non-Final OA | EASTERN VIRGINIA MEDICAL SCHOOL |
| 18023564 | LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | Cureport Inc. |
| 18017751 | PHOSPHOLIPID | Non-Final OA | NIPPON FINE CHEMICAL CO., LTD. |
| 17891061 | TREATMENT OF OPHTHALMOLOGICAL CONDITIONS WITH ACETYLCHOLINESTERASE INHIBITORS | Non-Final OA | ATTILLAPS HOLDINGS INC. |
| 17727956 | Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell | Final Rejection | Tron-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-University Mainz Gmb |
| 17635390 | ADHESIVE DRUG DELIVERY MICROPARTICLES AND A PRODUCT COMPRISING THEREOF | Final Rejection | AMD PHARMA LTD. |
| 17438195 | LOCALIZED DELIVERY OF THERAPEUTIC AGENTS | Non-Final OA | Nostopharma, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy